scholarly article | Q13442814 |
review article | Q7318358 |
P6179 | Dimensions Publication ID | 1046494511 |
P356 | DOI | 10.1007/S13277-015-4127-2 |
P932 | PMC publication ID | 4689759 |
P698 | PubMed publication ID | 26411672 |
P5875 | ResearchGate publication ID | 282350459 |
P2093 | author name string | Ting Han | |
Hai Hu | |||
Li-Wei Wang | |||
Feng Jiao | |||
P2860 | cites work | Exploring the full spectrum of macrophage activation | Q24653754 |
The pancreatic stellate cell: a star on the rise in pancreatic diseases | Q24676727 | ||
Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
Remodelling the extracellular matrix in development and disease | Q26864798 | ||
A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth | Q27345215 | ||
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy | Q27690653 | ||
Identification and expansion of human colon-cancer-initiating cells | Q27860627 | ||
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 | ||
Cancer statistics, 2014 | Q27861018 | ||
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer | Q28274188 | ||
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions | Q28293535 | ||
Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer | Q28384157 | ||
A PK2/Bv8/PROK2 antagonist suppresses tumorigenic processes by inhibiting angiogenesis in glioma and blocking myeloid cell infiltration in pancreatic cancer | Q28485246 | ||
Pancreatic Cancer | Q54135367 | ||
Genetic Deficiency in Plasma Protein HRG Enhances Tumor Growth and Metastasis by Exacerbating Immune Escape and Vessel Abnormalization | Q56999677 | ||
Stromal SPARC expression and patient survival after chemoradiation for non-resectable pancreatic adenocarcinoma | Q60609872 | ||
Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma | Q79600998 | ||
Cancer stem cells | Q80312237 | ||
Significance of M2-polarized tumor-associated macrophage in pancreatic cancer | Q84573386 | ||
Impact of tumor-associated macrophages on invasive ductal carcinoma of the pancreas head | Q84893126 | ||
Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis | Q37341261 | ||
An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. | Q37486791 | ||
Stromal biology and therapy in pancreatic cancer. | Q37802090 | ||
Adjuvant treatment of pancreatic cancer | Q37937922 | ||
Molecular link mechanisms between inflammation and cancer | Q38013290 | ||
The role of stroma in pancreatic cancer: diagnostic and therapeutic implications | Q38019761 | ||
Macrophages and angiogenesis: a role for Wnt signaling | Q38039501 | ||
Origin and turnover of monocytes and macrophages | Q38600410 | ||
Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. | Q40144497 | ||
Macrophages and angiogenesis | Q40386885 | ||
A better understanding of anti-inflammatory drugs based on isoforms of cyclooxygenase (COX-1 and COX-2). | Q40400101 | ||
Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells | Q40515728 | ||
Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis | Q42151300 | ||
Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancer | Q42214252 | ||
Lipopolysaccharide-activated macrophages stimulate the synthesis of collagen type I and C-fibronectin in cultured pancreatic stellate cells | Q42795032 | ||
Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity | Q44802879 | ||
Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. | Q45269853 | ||
Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity. | Q46373208 | ||
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages | Q46405799 | ||
The activated stroma index is a novel and independent prognostic marker in pancreatic ductal adenocarcinoma | Q46474773 | ||
Connective tissue growth factor (CCN2) in rat pancreatic stellate cell function: integrin alpha5beta1 as a novel CCN2 receptor | Q46687832 | ||
SHIP represses the generation of alternatively activated macrophages | Q46754459 | ||
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer | Q46781781 | ||
Cyclooxygenase-2 is required for activated pancreatic stellate cells to respond to proinflammatory cytokines | Q28569402 | ||
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis | Q29396371 | ||
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer | Q29547558 | ||
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial | Q29547565 | ||
New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
Prospective identification of tumorigenic prostate cancer stem cells | Q29547859 | ||
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer | Q29614302 | ||
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm | Q29614349 | ||
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer | Q29614599 | ||
Targeting hypoxia in cancer therapy | Q29615491 | ||
Tumorigenesis and the angiogenic switch | Q29619849 | ||
Cationic amino acid transporter-2 regulates immunity by modulating arginase activity | Q33325920 | ||
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis | Q33744153 | ||
Tumor associated macrophage × cancer cell hybrids may acquire cancer stem cell properties in breast cancer | Q34359276 | ||
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. | Q34429912 | ||
ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells | Q34446154 | ||
Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production | Q34556431 | ||
Macrophages regulate the angiogenic switch in a mouse model of breast cancer | Q34582812 | ||
Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. | Q34659689 | ||
Targeting tumor-associated macrophages as a novel strategy against breast cancer | Q34803221 | ||
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression. | Q35129307 | ||
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells | Q35134007 | ||
Cell migration: a novel aspect of pancreatic stellate cell biology | Q35595634 | ||
Combined blockade of integrin-α4β1 plus cytokines SDF-1α or IL-1β potently inhibits tumor inflammation and growth | Q35645125 | ||
Differential macrophage programming in the tumor microenvironment | Q35803027 | ||
Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. | Q35825254 | ||
In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters | Q35856477 | ||
Regulation of the chemokine receptor CXCR4 by hypoxia | Q36371842 | ||
Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses | Q36586333 | ||
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis | Q36601000 | ||
Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach | Q36612202 | ||
Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis | Q36980064 | ||
Macrophages and chemokines as mediators of angiogenesis | Q36983319 | ||
Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia | Q37040899 | ||
A starring role for stellate cells in the pancreatic cancer microenvironment | Q37059888 | ||
Pancreatic cancer stem cells. | Q37186408 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell | Q7868 |
macrophage | Q184204 | ||
adenocarcinoma | Q356033 | ||
pancreatic ductal carcinoma | Q8263002 | ||
hemic and immune systems | Q70202933 | ||
P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
P304 | page(s) | 9119-26 | |
P577 | publication date | 2015-12-01 | |
P1433 | published in | Tumor Biology | Q15757842 |
P1476 | title | Functional significance of macrophages in pancreatic cancer biology | |
P478 | volume | 36 |
Q99417952 | IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models |
Q61810548 | Inflammation and pancreatic cancer: An updated review |
Q47155954 | NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development. |
Q37624480 | Pancreatic stellate cell: Pandora's box for pancreatic disease biology |
Q58760423 | p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation |
Search more.